Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  V.KHRN.WT.H | KHRNF | KHRWF

Healthcare Cannabis
Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

TSXV:KHRN.H - Post Discussion

Khiron Life Sciences Corp > Carasco target price is $3.00 and another analyst has $6.00
View:
Post by 88guy88 on Feb 05, 2020 10:08am

Carasco target price is $3.00 and another analyst has $6.00

looks really cheap here at book value with huge potential.....nice return for patient investors...good luck
Comment by venus on Feb 06, 2020 11:54am
May I correct you: Jaime Carrasco recommended this stock at $2.20 with a target price of $6.00, he couldn't contain his excitement when recommending it.  When a viewer asked him again what his thoughts were on KHRN he said he was out of his position in the $2.00  range, then he has the balls to recommend it again at $1.60 with at target of $3.00.  One hell of a recommendation ...more  
Comment by Kyle2020 on Feb 06, 2020 8:48pm
stock is coming down to earth, to reflect a fairer value. At the end of the day it will be aquired for anywhere from .30-.60
Comment by LardsenLard on Feb 08, 2020 1:00pm
This post has been removed in accordance with Community Policy
Comment by LardsenLard on Feb 09, 2020 9:48am
This post has been removed in accordance with Community Policy
Comment by venus on Feb 10, 2020 1:03pm
That's correct, Jaime sold because he saw the writing on the wall and he needed BNN viewers to buy his shares, I was one of those suckers.  Now trading in the .60's, where to next?
Khiron Life Sciences Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities